Saturday, August 1, 2020
8 a.m. – 1 p.m., Central time
- 4.00 AMA PRA Category 1 Credit™
- 4.00 Attendance
Few treatments beyond supportive measures are available for patients critically ill with COVID-19. However, infusions of convalescent plasma from donors who have recovered from COVID-19 have demonstrated improvement in patient outcomes for illnesses like Ebola.
Mayo Clinic is currently leading a multicenter expanded access program to study treatment of COVID-19 with convalescent plasma. In this four-hour livestream event, course directors C. Scott Collins, M.D., Michael J. Joyner, M.D., R. Scott Wright, M.D., and other leading experts from Mayo Clinic, Johns Hopkins, and the U.S. Food and Drug Administration address:
- The history and evolution of convalescent plasma therapies.
- Implementation of the ongoing expanded access program for COVID-19 patients.
- Current data.
- Blood bank and donor recruitment strategies.
- World perspectives on treatment of COVID-19 patients with convalescent plasma.
- Moderated poster presentations and case sessions.